Investigation of drug interactions with pinaverium bromide.
A series of studies was carried out at 6 centres to investigate possible drug interaction between the spasmolytic, pinaverium bromide, and cardiac glycosides, anticoagulants and hypoglycaemic agents given to patients as part of the long-term treatment of their condition. The results of clinical and laboratory investigations did not show any evidence of pinaverium bromide interfering with the action or activity of any of the drugs studied.
Devred
C
C
Godeau
P
P
Guerot
C
C
Librez
P
P
Mougeot
G
G
Orsetti
A
A
Segrestaa
J M
JM
D000074:Acenocoumarol; D000293:Adolescent; D000328:Adult; D000368:Aged; D001777:Blood Coagulation / Q000187:drug effects; D001786:Blood Glucose / Q000378:metabolism; D004074:Digitoxin / Q000097:blood; D004077:Digoxin / Q000097:blood; D004311:Double-Blind Method; D004347:Drug Interactions; D005260:Female; D005905:Glyburide; D006493:Heparin; D006801:Humans; D007004:Hypoglycemic Agents; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000009:adverse effects*; D010276:Parasympatholytics / Q000009:adverse effects*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D009025:Morpholines; D010276:Parasympatholytics; D004077:Digoxin; D006493:Heparin; D004074:Digitoxin; D000074:Acenocoumarol; D005905:Glyburide; C013199:pinaverium